JP Morgan Chase’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
– Sell
-18,560
Closed -$177K – 5599
2017
Q4
$177K Hold
18,560
– – ﹤0.01% 4466
2017
Q3
$189K Buy
+18,560
New +$171K ﹤0.01% 4124

Other funds holding SEM

JP Morgan Chase's SEM Position: Q2 2026 in Review

JP Morgan Chase reduced its Select Medical (SEM) stake by 34% in Q2 2026, selling an estimated $1.64M and leaving 191,396 shares worth $3.24M. The position accounts for ﹤0.01% of the portfolio, ranked #3821.

JP Morgan Chase first reported a position in SEM in Q2 2013 and has held it in 52 quarters since. The position peaked at $25.2M in Q1 2021. 241 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • JP Morgan Chase held 191,396 shares of Select Medical worth $3.24M as of Q2 2026.
  • JP Morgan Chase sold 99,242 Select Medical shares in Q2 2026, an estimated $1.64M.
  • Select Medical made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3821 holding.
  • JP Morgan Chase first reported a position in Select Medical in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's Select Medical position peaked at $25.2M in Q1 2021.
  • 241 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.